Ligand Statistics

Code Name Deposits Targets Ligand Type
225 2 1 crystallization
2D8 2 2 crystallization
2NV 3,6,9,12,15-pentaoxaoctadecan-17-amine 1 1 crystallization
30N (3r,5s,9r)-1-[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-tr ihydroxy-8,8-dimethyl-10,14-dioxo-2,4,6-trioxa-11,15-di aza-3,5-diphosphaheptadecane-17-sulfinic acid 3,5-dioxi de (non-preferred name) 1 1 biological
3D1 (2r,3s,5r)-5-(6-amino-9h-purin-9-yl)-tetrahydro-2-(hydr oxymethyl)furan-3-ol 1 1 biological
3DS (4s,5r)-4,5-dihydroxy-3-oxocyclohex-1-ene-1-carboxylic acid 2 1 biological
3GR glyceraldehyde 1 1 other
3HB 1 1 biological
537 2,6-dihydroanthra/1,9-cd/pyrazol-6-one 1 1 crystallization
5GP guanosine-5'-monophosphate 2 2 biological
5WP 1 1 biological
5WQ 1 1 biological
649 5'-o-[(11-phenoxyundecanoyl)sulfamoyl]adenosine 1 1 biological
6JZ 3,6,9,12,15-pentaoxaheptadecane 2 2 other
6L0 1 1 biological
6PC 1 1 biological
6PG 6-phosphogluconic acid 1 1 biological
79V 2 1 crystallization
7CY (1r,2s,3r,5r)-3-(6-amino-9h-purin-9-yl)-5-(hydroxymethy l)cyclopentane-1,2-diol 1 1 biological
7PE 2-(2-(2-(2-(2-(2-ethoxyethoxy)ethoxy)ethoxy)ethoxy)etho xy)ethanol 1 1 crystallization
 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 
Page 2 of 26 | Show all